Accentia Biopharmace (ABPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2011 | 06-2011 | 03-2011 | 12-2010 | 09-2010 | |
| Sales | 757 | 1,067 | 1,220 | 912 | -2,932 |
| Cost of Goods | 651 | 628 | 657 | 554 | -2,709 |
| Gross Profit | 106 | 439 | 564 | 358 | -223 |
| Operating Expenses | 2,879 | 4,340 | 4,835 | 13,074 | -133 |
| Operating Income | -2,122 | -3,273 | -3,614 | -12,162 | -799 |
| Interest Expense | 1,778 | 1,869 | 2,055 | 2,392 | 2,881 |
| Other Income | 253 | 1,464 | 4,627 | 7,094 | -6,611 |
| Pre-tax Income | -3,647 | -3,678 | -1,042 | -7,460 | -10,291 |
| Income Tax | N/A | N/A | N/A | N/A | 6 |
| Net Income Continuous | -3,642 | -3,678 | -1,042 | -7,460 | -10,300 |
| Net Income Discontinuous | 222 | -57 | 14 | N/A | N/A |
| Minority Interests | -733 | -917 | 30 | -2,480 | 2,619 |
| Net Income | $-2,697 | $-2,818 | $-1,058 | $-4,981 | $-12,910 |
| EPS Basic Total Ops | 0.68 | -0.03 | -0.74 | -0.08 | -0.22 |
| EPS Basic Continuous Ops | 0.68 | -0.05 | -0.74 | -0.12 | -0.17 |
| EPS Diluted Total Ops | 0.68 | -0.03 | -0.74 | -0.08 | -0.22 |
| EPS Diluted Continuous Ops | 0.68 | -0.05 | -0.74 | -0.12 | -0.17 |
| EBITDA(a) | $-1,970 | $-3,134 | $-3,478 | $-12,028 | $-654 |